{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SEROQUEL+%28quetiapine+fumarate%29+Tablets&page=2", "query": { "intervention": "SEROQUEL (quetiapine fumarate) Tablets", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SEROQUEL+%28quetiapine+fumarate%29+Tablets&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=SEROQUEL+%28quetiapine+fumarate%29+Tablets&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T20:55:04.325Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00325689", "title": "Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Quetiapine or Risperidone + Aripiprazole", "type": "DRUG" }, { "name": "Quetiapine or Risperidone + placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 323, "start_date": "2006-07", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 48, "location_summary": "Little Rock, Arkansas • Cerritos, California • Costa Mesa, California + 37 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Granada Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00325689" }, { "nct_id": "NCT00389064", "title": "Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anxiety Disorders" ], "interventions": [ { "name": "Quetiapine XR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "66 Years", "maximum_age": null, "sex": "ALL", "summary": "66 Years and older" }, "enrollment_count": 450, "start_date": "2006-09", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2012-04-04", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 14, "location_summary": "Fort Myers, Florida • Gainsville, Florida • Miami, Florida + 11 more", "locations": [ { "city": "Fort Myers", "state": "Florida" }, { "city": "Gainsville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00389064" }, { "nct_id": "NCT00183443", "title": "Treatment of Mania Symptoms With Drug Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder", "Schizophrenia" ], "interventions": [ { "name": "Divalproex-extended release (DVP-ER)", "type": "DRUG" }, { "name": "Lithium", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palo Alto Veterans Institute for Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 75, "start_date": "2005-02", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2018-07-17", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00183443" }, { "nct_id": "NCT05542264", "title": "A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "SEP-363856", "type": "DRUG" }, { "name": "Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2022-11-15", "completion_date": "2024-02-12", "has_results": false, "last_update_posted_date": "2024-06-26", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 4, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Dayton, Ohio + 1 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Dayton", "state": "Ohio" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05542264" }, { "nct_id": "NCT00619892", "title": "A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Panic Disorder" ], "interventions": [ { "name": "quetiapine XR", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 26, "start_date": "2008-02", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2016-01-21", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00619892" }, { "nct_id": "NCT00090324", "title": "Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "quetiapine fumarate tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 249, "start_date": "2004-09", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2013-01-04", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 23, "location_summary": "Dothan, Alabama • Cerritos, California • Riverside, California + 20 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00090324" }, { "nct_id": "NCT00631748", "title": "Quetiapine for the Reduction of Cocaine Use", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cocaine Dependence", "Cocaine Abuse", "Cocaine Addiction", "Drug Abuse", "Substance Abuse" ], "interventions": [ { "name": "quetiapine fumarate", "type": "DRUG" }, { "name": "Matched Placebo", "type": "DRUG" }, { "name": "Cognitive-behavioral Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Seattle Institute for Biomedical and Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2008-02", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2014-03-31", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00631748" }, { "nct_id": "NCT01129674", "title": "A Long-Term, Open-Label, Study on Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denovo Biopharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 560, "start_date": "2010-06", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 42, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 39 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129674" }, { "nct_id": "NCT05402111", "title": "A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "SEP-363856", "type": "DRUG" }, { "name": "Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2022-06-13", "completion_date": "2023-09-27", "has_results": false, "last_update_posted_date": "2024-06-26", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 7, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Long Beach, California + 4 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05402111" }, { "nct_id": "NCT02131545", "title": "Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dementia", "Delirium" ], "interventions": [ { "name": "Quetiapine 25 mg gel applied topically", "type": "DRUG" }, { "name": "Quetiapine 25 mg tablet by mouth", "type": "DRUG" }, { "name": "Quetiapine 25 mg rectal suppository", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2014-06", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-10-11T20:55:04.325Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02131545" } ] }